Press Releases

March 9, 2017
iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System
Read More

March 3, 2017
iCAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment at AAD 2017
Read More

December 6, 2016
First-Ever Analysis of Intraoperative Radiation Therapy with Xoft System as a Boost Prior to Whole Breast Radiation to be Presented at San Antonio Breast Cancer Symposium
Read More

September 26, 2016
iCAD to Present Positive Clinical Data Supporting Use of Xoft System for Early-Stage Breast Cancer and Nonmelanoma Skin Cancer at ASTRO 2016
Read More

June 28, 2016
First Cervical Cancer Patient Treated in Europe with the Xoft System at Hospital Universitario Miguel Servet in Spain
Read More

March 4, 2016
iCAD Showcases Latest Technology Supporting Use of Xoft System for Non-melanoma Skin Cancer Treatment at AAD 2016
Read More

December 8, 2015
Researchers to Present Updated Data Regarding Intraoperative Radiation Therapy with the Xoft System at San Antonio Breast Cancer Symposium

Read More

November 23, 2015
iCAD Reports Use of Xoft® Axxent® Electronic Brachytherapy System in the Treatment of More than 15,000 Non-Melanoma Skin Cancer Lesions

Read More

November 18, 2015
iCAD’s Xoft System Selected as a Popular Science Magazine “Best of What’s New” Award Winner for 2015
Read More

Sept. 30, 2015
iCAD Launches National Educational Program to Increase Awareness of the Effective Use of Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer
Read More

July 13, 2015
Read More

May 27, 2015
iCAD, Inc. Withdraws 2015 Financial Guidance Due to General Reimbursement Uncertainty
Read More

May 06, 2015
iCAD, Inc. Announces Information Related To Reimbursement Levels
Read More

May 05, 2015
iCAD Launches Digital Customer Training Platform to Support Professional Education in Use of Xoft System for Treatment of Non-Melanoma Skin Cancer, Early-Stage Breast Cancer and Gynecological Cancers
Read More

April 24, 2015
First Hospital in Spain Adopts Xoft Electronic Brachytherapy System for the Treatment of Early-stage Breast Cancer, Non-melanoma Skin Cancer and Gynecological Cancers
Read More

April 07, 2015
Positive Clinical Data for iCAD’s Xoft System to be Highlighted at American Brachytherapy Society (ABS) Annual Meeting
Read More

March 20, 2015
iCAD to Present Positive Four-year Data on Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for Non-melanoma Skin Cancer (NMSC)
Read More

«« Press Release Archive »»

Quick Links

Public Relations

Berry & Company
Public Relations, LLC

Jessica Burns

+1 212 253 8881

All Xoft treatments must be performed with a thorough knowledge of radiation physics, proper planning, dosimetric calculations and knowledge of radio-biological effectiveness; therefore, we require that a radiation therapist/oncologist administer the use of the Xoft Electronic Brachytherapy (eBx) System. We do not support the use of the Xoft System by anyone other than radiation professionals (trained and certified). We rigorously enforce this, as patient safety and efficacy is preeminent to us.

©2017 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.